FDA NDC Directory · JSON-LD · Markdown

Duloxetine

NDC 0228-2891 · HUMAN PRESCRIPTION DRUG · CAPSULE, DELAYED RELEASE PELLETS

Labeler / ManufacturerActavis Pharma, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA090776
Dosage form / routeCAPSULE, DELAYED RELEASE PELLETS · ORAL
Active ingredientsDULOXETINE HYDROCHLORIDE (30 mg/1)
Marketing started20131217
Package count2

External sources

Source: openFDA. Public-domain (CC0).